To be included, men and women had to be at least 18 years of age, have a prior diagnosis of IBS made by a health care provider, and had to report current IBS symptoms (Rome-II criteria). Participants were excluded if they had a history of co-existing GI pathology (e.g., inflammatory bowel disease, celiac disease) or surgery (e.g., bowel resection), renal, or reproductive pathology (e.g., endometriosis, prostate cancer). Participants with certain other comorbidities or medication use were also excluded, based on the guiding principle of whether the disorder or medications could confound the measurement of the symptoms of IBS or compromise the subject’s ability to complete the study. Subjects were excluded for conditions such as severe fibromyalgia, type 1 or 2 diabetes mellitus, infectious diseases (e.g., hepatitis B or C, HIV), symptoms of dementia, untreated sleep apnea/hypopnea, severe cardiovascular disease, severe depression, and current substance abuse. Examples of medications that lead to exclusion included the regular use of antibiotics, anticholinergics, cholestyramine, narcotics, colchicine, docusate, enema preparations, iron supplements, or laxatives. Human subjects institutional review approval was obtained prior to enrolling participants (May 2002) and renewed yearly thereafter. This study was registered with clinicaltrials.gov through the U.S. National Institutes of Health.
>
Procedures
>
Therapeutic or Preventive Procedure
>
Enema
Enema
An enema is a procedure in which liquid or gas is injected into the rectum to cleanse the lower bowel.
Enemas can be used for a variety of medical purposes, such as relieving constipation, administering medications, or preparing the bowel for diagnostic tests or surgery.
The liquid used in an enema can be water, saline, or a medicated solution, depending on the specific purpose.
Enemas are generally considered safe when performed correctly, but they do carry some risks, such as electrolyte imbalances or bowel perforation.
Researchers studying enema procedures can use the PubCompare.ai platform to streamline their work, locating the best protocols from published literature and comparing them to enhance reproducibility and accuracy.
This AI-driven tool helps optimize enema reserach by providing intelligent comparisons and insights to support researchers in this important area of study.
Enemas can be used for a variety of medical purposes, such as relieving constipation, administering medications, or preparing the bowel for diagnostic tests or surgery.
The liquid used in an enema can be water, saline, or a medicated solution, depending on the specific purpose.
Enemas are generally considered safe when performed correctly, but they do carry some risks, such as electrolyte imbalances or bowel perforation.
Researchers studying enema procedures can use the PubCompare.ai platform to streamline their work, locating the best protocols from published literature and comparing them to enhance reproducibility and accuracy.
This AI-driven tool helps optimize enema reserach by providing intelligent comparisons and insights to support researchers in this important area of study.
Most cited protocols related to «Enema»
Antibiotics
Anticholinergic Agents
Apnea
Cardiovascular Diseases
Celiac Disease
Colchicine
Communicable Diseases
Dementia
Diabetes Mellitus
Diagnosis
Dietary Supplements
Docusate
Endometriosis
Enema
Fibromyalgia
Health Personnel
Hepatitis B
Homo sapiens
Inflammatory Bowel Diseases
Intestines
Iron
Kidney
Laxatives
Narcotics
Operative Surgical Procedures
Pharmaceutical Preparations
Prostate Cancer
Reproduction
Resin, Cholestyramine
Sleep Apnea Syndromes
Substance Abuse
Woman
Anesthesia
Antibiotic Prophylaxis
Biopsy
Core Needle Biopsy
Enema
Malignant Neoplasms
Patients
Pelvis
Prostate
Prostate Cancer
Ultrasonography
MRI and CT scans for treatment planning were performed 7 days after fiducial implantation to ensure adequate tissue fixation and to allow for resolution of procedural edema/inflammation (Poggi et al., 2003 (link); Pouliot et al., 2003 (link); Kupelian et al., 2005 (link)). Precautions were taken to minimize prostate motion during the planning scans and treatment. Specifically, starting 5 days prior to acquisition of the planning scans until the end of treatment, patients maintained a low fiber diet to reduce intestinal gas (Smitsmans et al., 2008 (link)). Fasts were also initiated 4 h before both acquisition of the planning scans and each treatment session to minimize rectal movement. Enemas were performed 2 h prior to acquisition of the planning scans and each treatment session to minimize rectal volume. All patients were imaged and treated in the supine treatment position with a knee cushion to maximize patient comfort and limit prostate motion in response to respiration (Malone et al., 2000 (link)).
Fused thin cut CT images (1.25 mm) and high-resolution MR images were used for treatment planning (Figures3 A–C). MRI imaging was employed to define the target volume (Roach et al., 1996 (link)) and to aid in accurate localization of the bladder neck, membranous urethra, and penile bulb (Mclaughlin et al., 2005 (link)). Intra-prostatic fiducials were employed to guide image co-registration and limit fusion errors (Parker et al., 2003 (link)). MR images were obtained on a 1.5-T scanner in a phased-array torso coil. The MRI was quickly (<1 h) followed by a CT scan to minimize anatomical changes in the rectum that may interfere with image fusion. Two MRI sequences were employed to maximize visualization of the fiducials (susceptibility-weighted gradient-echo images) and the soft tissues (axial high-resolution turbo T2-weighted spin-echo images). Treatment planning included the prostate as the gross target volume (GTV). The CTV included the prostate and the proximal seminal vesicles. The PTV equaled the CTV expanded by 3 mm posteriorly and 5 mm in all other dimensions. Treatment planning was generally completed within 1 week of imaging and subsequent treatment was initiated within a 1- to 2-week window.
Fused thin cut CT images (1.25 mm) and high-resolution MR images were used for treatment planning (Figures
ECHO protocol
Edema
Enema
Fibrosis
Inflammation
Intestines
Knee
Medulla Oblongata
Movement
Neck
Ovum Implantation
Patients
Penis
Prostate
Radionuclide Imaging
Rectum
Respiration
Seminal Vesicles
Susceptibility, Disease
Therapy, Diet
Tissue, Membrane
Tissue Fixation
Tissues
Torso
Urethra
Urinary Bladder
X-Ray Computed Tomography
Diagnosis
Diuretics
Enema
Fat-Restricted Diet
Fear
Feelings
Food
Guilt
Hunger
Laxatives
Parts, Body
Pharmaceutical Preparations
The generation of ITF null mice has been described previously 21 . Intestinal permeability was examined in 6–10-wk-old wild-type Bl6129 (Taconic, Inc.) or ITF null mice using an FITC-labeled dextran method as described previously 22 . Mice were gavaged with 60 mg/100 g body weight of FITC-dextran (4,000 kD at 80 mg/ml; Sigma-Aldrich) and exposed to ambient hypoxia (8% O2, 92% N2) or ambient room air for various times (n = 4–6 per condition). In some experiments, mice were administered either recombinant human ITF (30 mg/kg, 75% gastric lavage, 25% enema) or PBS 1 h before hypoxia. Cardiac puncture was performed and serum analysis of FITC concentration performed. In subsets of experiments, tissues were collected from wild-type and ITF null mice after hypoxia and fixed in 10% buffered formalin. 5-μm sections were cut, stained with hematoxylin and eosin, and histologically characterized. Colonic tissue was harvested and homogenized and RNA extracted with Trizol as described above. Another section of colonic mucosal scrapings was harvested and processed for Western blot analysis as described above. This protocol was in accordance with National Institutes of Health guidelines for use of live animals and was approved by the Institutional Animal Care and Use Committee at Brigham and Women's Hospital.
Animals
Body Weight
Colon
Enema
Eosin
Fluorescein-5-isothiocyanate
fluorescein isothiocyanate dextran
Formalin
Gastric Lavage
Heart
Homo sapiens
Hypoxia
Institutional Animal Care and Use Committees
Intestines
Mice, House
Mice, Knockout
Mucous Membrane
Permeability
Punctures
Serum
Tissues
trizol
Western Blot
Most recents protocols related to «Enema»
Example 6
The organ bath system represents an ex vivo system lacking central nervous system (CNS) connections. Gastrointestinal motility is investigated using mice as an animal model. Experiments are performed to measure colonic contractility in conscious germ free (GF) and colonized mice with infusion of tryptamine by enema as well as following colonization of GF with tryptamine producing E. coli. The effect of tryptamine on epithelial biology also is determined.
Animal Model
Bath
Central Nervous System
Colon
Consciousness
Enema
Escherichia coli
Gastrointestinal Motility
Mus
Muscle Contraction
Tryptamines
The study included 229 children who underwent emergency surgical treatment for AIO and who had previously (primarily) been operated on: acute appendicitis -137 (59.8%), introsusception -36 (15.7%), blunt abdominal trauma -34 (14.8%), necrotizing enterocolitis -15 (6.5%), liver echinococcosis -5 (2.2%), and Payer’s disease -2 (0.9%). Boys to girls ratio made 1.3:1. The average age of the patients was 9.8±1.7 years old. Group 1 included 116 children, Group 2–113. The study was conducted in the clinical facilities of Stavropol Regional Children’s Clinical Hospital, Grozny Children’s Clinical Hospital No 2, and Makhachkkala Republican Children’s Clinical Hospital.
On children with the signs of AIO, treatment was started with conservative measures in the form of nasogastric intubation, infusion therapy, cleansing, and saline enema. No effect of the conducted treatment was the indication for surgery. The surgical treatment consisted of the elimination of cause of the mechanical intestinal obstruction (dissection of adhesions, untwisting, and laying the sentinel loops in the physiological position, and so on). Children who underwent colostomy were not included in this study.
The author’s method was used for all Group 1 children within the first 4 days of the post-operative period. Then, for up to 5–6 days (11 patients) of the post-operative period, the procedure was continued for the patients that were somewhat difficult to activate due to their young age, degree of severity of the post-operative condition, patient, pronounced predisposition to adhesions.
In the post-operative period, the abdominal brain exposure to the variable magnetic field was used for Group 2 to arrest the intestinal distention. The device “Magniter” was applied to the anterior abdominal wall for 20 min daily during the first 4 days of the post-operative period. From 5 to 15 post-operative days, the control group of patients received electrophoresis with hyaluronidase 64 IU.
During the treatment efficacy assessment, the following criteria were considered: Subjective data (intensity of pain and asthenic syndrome and quality of life); objective data, including the dynamics of symptoms (pain, edema, and hyperemia) and period of the patients staying at the hospital.
The adhesive process in the abdomen was determined using the Androsov, Blonov, and Knokh position specimens. These specimens are based on the creation of the thrust vector during mechanical tractions causing the adhesion tensioning between points of its attachment to various sites of the abdomen. Pain appearance or intensification is clinically determined.
The ultrasound examination of the abdomen was performed on GE Pro series LOGIQ 500 and SonoAce PICO using the curvilinear transabdominal multifrequency transducers within the range from 3.5 to 7.5 MHz. The echostructure of the abdomen, mobility of parietal and visceral peritoneum, “return” symptoms and small bowel dyskinesia in the area of its fixation by adhesives were examined.
On children with the signs of AIO, treatment was started with conservative measures in the form of nasogastric intubation, infusion therapy, cleansing, and saline enema. No effect of the conducted treatment was the indication for surgery. The surgical treatment consisted of the elimination of cause of the mechanical intestinal obstruction (dissection of adhesions, untwisting, and laying the sentinel loops in the physiological position, and so on). Children who underwent colostomy were not included in this study.
The author’s method was used for all Group 1 children within the first 4 days of the post-operative period. Then, for up to 5–6 days (11 patients) of the post-operative period, the procedure was continued for the patients that were somewhat difficult to activate due to their young age, degree of severity of the post-operative condition, patient, pronounced predisposition to adhesions.
In the post-operative period, the abdominal brain exposure to the variable magnetic field was used for Group 2 to arrest the intestinal distention. The device “Magniter” was applied to the anterior abdominal wall for 20 min daily during the first 4 days of the post-operative period. From 5 to 15 post-operative days, the control group of patients received electrophoresis with hyaluronidase 64 IU.
During the treatment efficacy assessment, the following criteria were considered: Subjective data (intensity of pain and asthenic syndrome and quality of life); objective data, including the dynamics of symptoms (pain, edema, and hyperemia) and period of the patients staying at the hospital.
The adhesive process in the abdomen was determined using the Androsov, Blonov, and Knokh position specimens. These specimens are based on the creation of the thrust vector during mechanical tractions causing the adhesion tensioning between points of its attachment to various sites of the abdomen. Pain appearance or intensification is clinically determined.
The ultrasound examination of the abdomen was performed on GE Pro series LOGIQ 500 and SonoAce PICO using the curvilinear transabdominal multifrequency transducers within the range from 3.5 to 7.5 MHz. The echostructure of the abdomen, mobility of parietal and visceral peritoneum, “return” symptoms and small bowel dyskinesia in the area of its fixation by adhesives were examined.
Abdomen
Abdominal Cavity
Appendicitis
Boys
Brain
Cardiac Arrest
Child
Cloning Vectors
Colostomy
Debility
Dissection
Dyskinesias
Echinococcosis, Hepatic
Edema
Electrophoresis
Emergencies
Enema
Hyaluronidase
Hyperemia
Injury, Abdominal
Intestinal Obstruction
Intestines
Intestines, Small
Intubation, Nasogastric
Intussusception
Magnetic Fields
Medical Devices
Necrotizing Enterocolitis
Operative Surgical Procedures
Pain
Patients
physiology
Range of Motion, Articular
Saline Solution
Severity, Pain
Susceptibility, Disease
Syndrome
Traction
Transducers
Treatment, Emergency
Ultrasonography
Visceral Peritoneum
Wall, Abdominal
Woman
12 patients received therapy with FMT plus PEN (80%). The guardians of the 12 patients refused immunological interventions, considering the adverse effects of corticosteroids and immunosuppressants, and they agreed to FMT as first-line therapy. The number of FMT infusions was grouped into single (1 day) or multiple infusions (2-10 days continuously). No bowel preparation (cleanup or laxative administration) was performed before the FMT. The donor feces were collected 1 h pre-FMT, attenuated, and mingled with sterile normal saline (1 mg of feces was attenuated with 5ml of saline). Samples were filtered through sterile gauze, and a 100mL fresh fecal microbiota suspension was prepared for the FMT. The fecal suspension was poured into a sterile cup for the FMT procedure within 1 h. The routes of administration included colonoscopy and enema. Fecal microbiota transplantation (FMT) were performed by colonoscopy (Figures 2A, B ). Fecal microbiota transplantation (FMT) were performed by retention enema (Figures 2C, D ). After infusion, the patients were asked to hold a fixed position (>25° semi-reclining or hip-up position) for at least 4 h. The FMT procedure followed a uniform standard for each patient. All the patients in the FMT group received fresh fecal suspensions.
Adrenal Cortex Hormones
Colonoscopy
Donors
Enema
Fecal Microbiota Transplantation
Feces
Immunosuppressive Agents
Intestines
Laxatives
Legal Guardians
Microbial Community
Normal Saline
Patients
Retention (Psychology)
Saline Solution
Strains
Therapeutics
A 31-year-old incarcerated AA male complained of hematochezia and fever requiring admission to the hospital and was diagnosed with Clostridium difficile colitis. CT scan and colonoscopy showed left-sided colitis. Following treatment with oral vancomycin, outpatient colonoscopy was consistent with residual proctosigmoiditis. Through SDM, he was started on mesalamine enemas but had difficulty retaining them and decision was made to start on UST for ease of dosing and avoidance of per-rectum therapies per patient preference. The UST was infused at the clinic during a scheduled visit. He missed multiple doses due to inconsistent transport to clinic for nurse-led administration of medication. He was then released from custody and off all therapy until developing C. difficile infection requiring hospitalization. He was treated with vancomycin and then resumed on PO and PR mesalamine as an outpatient. However, upon reincarceration with questionable access to medication, he developed worsening symptoms and was started on sulfasalazine. Repeat colonoscopy showed Mayo 3 pancolitis with pathology confirming moderate inflammation. He resumed UST therapy with a standard loading dose given at a clinic appointment and 90 mg SC every 8 weeks consistently while incarcerated. The patient has since been released from the detention center and has a steady job. He has been in frequent contact with the PCMH and the behavioral health social worker who assists him in coming to appointments and receiving his medication in a timely fashion from the specialty pharmacy. Clinically, he is doing well and is planned for endoscopic evaluation shortly once his insurance is valid. Additional biochemical evaluation is pending given the cost associated with self-pay laboratory studies.
Administration, Oral
Clostridium difficile
Colitis
Colonoscopy
Endoscopy
Enema
Fever
Hematochezia
Hospitalization
Infection
Inflammation
Males
Mesalamine
Nurses
Outpatients
Patients
Pharmaceutical Preparations
Proctosigmoiditis
Sulfasalazine
Therapeutics
Vancomycin
Worker, Social
X-Ray Computed Tomography
When identifying an acute MOPC, specialized gastroenterologists and colorectal surgeons selected either SEMS or diverting loop ileostomy as a BTS, considering the location and severity of the obstructing lesion, availability of SEMS, and risk of perforation. In cases of SEMS, the location and etiology of acute bowel obstruction are revealed by colonoscopy after bowel cleaning with a simple enema. The guidewire was positioned under fluoroscopy, and suitable stents were placed according to the standard method (Fig. 1 ) [16 (link)]. All the SEMSs used were uncovered (BONASTENT, Seoul, Korea; or HANAROSTENT, Seoul, Korea) and had a diameter of 24 mm and length of 60, 80, 100, or 120 mm.
Loop ileostomy was performed using a routine surgical approach [17 ]. After the abdominal wall incision at the ileostomy site, the tension-free loop of the distal ileum was pulled out of the abdominal wall to create a stoma. The sutures were then placed for mature and evert loop ileostomy. Curative resection can be performed in eligible patients after decompression of the bowel. The time of surgery was determined according to the patients’ general condition and co-morbidities and the degree of edematous bowel at the time of BTS. The surgical method was either right hemicolectomy (RHC) or extended RHC, depending on the location of the tumor. Investigation of complications and short-term outcomes associated with SEMS insertion or diverting ileostomy was performed. The result of curative resection after BTS was also analyzed for the corresponding patients to evaluate the long-term effect of the two bridge modalities.
Loop ileostomy was performed using a routine surgical approach [17 ]. After the abdominal wall incision at the ileostomy site, the tension-free loop of the distal ileum was pulled out of the abdominal wall to create a stoma. The sutures were then placed for mature and evert loop ileostomy. Curative resection can be performed in eligible patients after decompression of the bowel. The time of surgery was determined according to the patients’ general condition and co-morbidities and the degree of edematous bowel at the time of BTS. The surgical method was either right hemicolectomy (RHC) or extended RHC, depending on the location of the tumor. Investigation of complications and short-term outcomes associated with SEMS insertion or diverting ileostomy was performed. The result of curative resection after BTS was also analyzed for the corresponding patients to evaluate the long-term effect of the two bridge modalities.
Colonoscopy
Decompression
Edema
Enema
Fluoroscopy
Gastroenterologist
Hemicolectomy
Ileostomy
Ileum
Intestinal Obstruction
Intestines
Longterm Effects
Loop Ileostomies
Neoplasms by Site
Operative Surgical Procedures
Patients
Stents
Surgeons
Surgical Stoma
Sutures
Wall, Abdominal
Top products related to «Enema»
Sourced in United States, France, Germany, China, Canada, United Kingdom, Australia, Japan, Panama, Philippines
The DSS is a laboratory instrument designed for the separation and analysis of molecules and particles in complex samples. It utilizes a specialized technique called differential sedimentation to achieve precise separation and characterization of the components within a sample. The core function of the DSS is to provide accurate and reliable data on the size, distribution, and concentration of the analytes present, without interpretation or extrapolation on its intended use.
Sourced in Germany, United States
Buscopan is a pharmaceutical product developed by Boehringer Ingelheim. It contains the active ingredient hyoscine butylbromide, which acts as an antispasmodic agent.
Sourced in Netherlands, Germany, United States, United Kingdom, Japan
The Philips Achieva is a versatile laboratory equipment designed for a range of analytical and research applications. It offers advanced capabilities for tasks such as sample preparation, separation, and detection. The Achieva is engineered to provide reliable and consistent performance, making it a valuable tool for various scientific disciplines.
Sourced in Germany, United States
The MAGNETOM Skyra is a magnetic resonance imaging (MRI) system developed by Siemens. It is designed to provide high-quality imaging for various medical applications. The MAGNETOM Skyra utilizes advanced technology to generate detailed images of the body's internal structures without the use of ionizing radiation.
Sourced in United States
The Intramedic PE-20 tubing is a medical-grade polyethylene tubing designed for laboratory applications. It is a flexible, transparent tubing with a consistent inner diameter of 0.38 mm and an outer diameter of 1.09 mm. The tubing is suitable for use in a variety of laboratory setups, including fluid transfer, sample collection, and connection of various devices.
Sourced in Japan, Germany, United States
The Aquilion 64 is a computed tomography (CT) scanner manufactured by Toshiba. It is designed to capture high-quality, three-dimensional images of the human body. The Aquilion 64 is capable of producing 64 slices of image data per rotation, allowing for rapid and efficient data acquisition.
Sourced in Germany, United States, United Kingdom, France, Switzerland, Netherlands, Canada, Spain, Italy, Japan, Denmark, Australia, Sweden
The TissueLyser is a laboratory equipment designed for rapid and efficient disruption of biological samples. It utilizes bead-beating technology to homogenize a wide range of sample types, including plant, animal, and microbial tissues. The TissueLyser is a versatile tool that enables efficient sample preparation for various downstream applications.
Sourced in Italy, United States, Japan
FLOQSwabs are a type of laboratory sampling device designed for the collection of biological samples. They feature a flocked tip that enhances sample collection and transfer. The core function of FLOQSwabs is to facilitate the efficient and accurate gathering of specimens for various analytical and diagnostic applications.
Sourced in Germany, United States, Netherlands, United Kingdom, France, Australia
RLT lysis buffer is a guanidine-thiocyanate-containing lysis buffer designed for efficient lysis and homogenization of biological samples to facilitate subsequent RNA extraction and purification.
Sourced in United States
The Manoscan is a diagnostic device used for the assessment of esophageal motility. It measures pressure changes within the esophagus, providing data on the function and coordination of the esophageal muscles.
More about "Enema"
enema, rectal administration, clyster, bowel cleansing, constipation relief, medication administration, diagnostic test preparation, surgical preparation, saline enema, medicated enema, PubCompare.ai, enema research, enema protocols, enema reproducibility, enema accuracy, Buscopan, Achieva, MAGNETOM Skyra, Intramedic PE-20 tubing, Aquilion 64, TissueLyser, FLOQSwabs, RLT lysis buffer, Manoscan